• S2 Ep8: The FDA Decision for Pompe Disease Therapy

  • 2022/10/28
  • 再生時間： 13 分
  • ポッドキャスト

S2 Ep8: The FDA Decision for Pompe Disease Therapy

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • The FDA is expected to announce the final decision for the dual therapy AT-GAA, which uses miglustat in combination with cipaglucosidase alfa for treating Pompe disease, an inherited and often times fatal disorder. Expert Barry Byrne discusses the characteristics of the condition and what this FDA decision will mean for treatment.
    続きを読む 一部表示
activate_samplebutton_t1

あらすじ・解説

The FDA is expected to announce the final decision for the dual therapy AT-GAA, which uses miglustat in combination with cipaglucosidase alfa for treating Pompe disease, an inherited and often times fatal disorder. Expert Barry Byrne discusses the characteristics of the condition and what this FDA decision will mean for treatment.
続きを読む 一部表示

S2 Ep8: The FDA Decision for Pompe Disease Therapyに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。